TET2 and breast carcinoma: Recent study reports that 5-hmC level is decreased in metastatic tissues of nasopharyngeal carcinoma, breast cancer, and colon cancer, compared with non-metastasis tumor tissues, and TET2 is involved in the process of tumor metastasis [14].